Brimosun LS Eye Drop
By Brimosun LS
Rx
5ml Eye Drop in a Packet

Composition
Brimonidine(0.1% w/v)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
May, 2026

liver
For the safety of your liver while using Brimosun LS Eye Drop, it is important to note that there are no known interactions or established risks related to liver issues. It is always recommended to consult with your doctor for proper guidance before using any medication, including Brimosun LS Eye Drop. Taking this precaution ensures your safety and helps to prevent any potential complications.

kidney
No interaction has been found or established relating to kidney issues with Brimosun LS Eye Drop.

alcohol
No interaction has been found or established between Brimosun LS Eye Drop and alcohol. It is always important to consult your doctor when consuming alcohol with any medication, including Brimosun LS Eye Drop. It is advised to exercise caution during pregnancy.

driving
When using Brimosun LS Eye Drop, be cautious while driving as it may cause blurred or abnormal vision, especially in low light, impacting your ability to drive safely.

pregnancy
Brimosun LS Eye Drop is believed to be safe for use during pregnancy, based on animal studies that showed minimal impact on fetal development. Human studies are limited, so consult your healthcare provider if unsure.

breastfeeding
Brimosun LS Eye Drop is considered safe during breastfeeding with limited human data indicating low risk to the baby. To minimize transfer to breastmilk, apply pressure on the eye corner and remove excess solution with a tissue.
Habit Forming | No |
Chemical Class | Quinoxaline Derivative |
Therapeutic Class | - |
Action Class | Sympathomimetics- Ocular |
₹299
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024